Related Experiment Video
Updated: Jul 21, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Novel Insights into the Link Between Myeloperoxidase Modified LDL, LOX-1, and Neuroserpin in Stroke
Layal El-Hajjar1, Elena Miranda2, Marwan El-Sabban1
1Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, 1107 Beirut, Lebanon.
Insights
Myeloperoxidase oxidized LDL (Mox-LDL) impairs endothelial cell fibrinolysis by increasing neuroserpin, but the lectin-like oxidized LDL receptor-1 (lox-1) mitigates this effect. Lox-1 protects against Mox-LDL-induced decreases in fibrinolytic capacity, impacting stroke risk.
Area of Science:
- Cardiovascular Research
- Endothelial Cell Biology
- Atherosclerosis Pathophysiology
Background:
- Atherosclerosis, a major cause of global mortality, stems from endothelial dysfunction and modified LDL accumulation.
- Myeloperoxidase oxidized LDL (Mox-LDL) is implicated in atherosclerosis, potentially through binding to the lectin-like oxidized LDL receptor-1 (lox-1) and promoting inflammation.
- Neuroserpin, a serine proteinase inhibitor, plays a role in fibrinolysis within nervous tissue.
Purpose of the Study:
- To investigate the in vitro effects of Mox-LDL on the fibrinolytic activity of human aortic endothelial cells (HAECs).
- To determine the role of the lox-1 scavenger receptor in mediating Mox-LDL's impact on endothelial fibrinolysis.
- To assess neuroserpin expression and release in response to Mox-LDL and lox-1 activity.
Main Methods:
- Utilized lox-1 gene silencing in HAECs to evaluate the receptor's role.
- Cultured cells with Mox-LDL and measured neuroserpin expression via qPCR and ELISA.
- Assessed endothelial cell fibrinolytic activity using the Euglobulin Clot Lysis Time (ECLT) method.
Main Results:
- Mox-LDL was found to decrease endothelial cell fibrinolytic capacity.
- This decrease in fibrinolytic capacity was associated with increased neuroserpin levels in lox-1 knockdown cells.
- Upregulation of neuroserpin correlated with reduced fibrinolytic activity.
Conclusions:
- The lectin-like oxidized LDL receptor-1 (lox-1) plays a protective role for endothelial cells against Mox-LDL.
- Lox-1 mitigates Mox-LDL-induced reductions in pro-fibrinolytic capacity.
- These findings have significant implications for understanding stroke pathogenesis and potential therapeutic targets.
Background:
Cardiovascular disease that is caused by atherosclerosis is the leading cause of death worldwide. Atherosclerosis is primarily triggered by endothelial dysfunction and the accumulation of modified low-density lipoprotein (LDL) particles in the subendothelial space of blood vessels. Early reports have associated oxidized LDL with altered fibrinolysis and atherogenesis. It has been suggested that myeloperoxidase oxidized LDL (Mox-LDL) is involved in atherosclerosis because of its significant pathophysiological role in the modification of LDL in vivo. It has been equally demonstrated that Mox-LDL binds to the lectin-like oxidized low-density lipoprotein receptor-1 (lox-1) scavenger receptor which leads to the upregulation of inflammatory mediators in endothelial cells and the progression of cardiovascular disease. It has been also shown that neuroserpin, a member of the serine proteinase inhibitor (serpin) superfamily, has an important role at the level of fibrinolysis in the nervous tissue.
Methods:
Since little is known about the effects of Mox-LDL on endothelial cell fibrinolytic activity and the involvement of lox-1 in this process, our study aimed at evaluating the in vitro effects of Mox-LDL on neuroserpin release from human aortic endothelial cells (HAECs) and the role of lox-1 scavenger receptor in this context by relying on lox-1 gene silencing in HAECs, culturing the cells in the presence of Mox-LDL, measuring their neuroserpin expression and release by quantitative polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA), respectively, and assessing their fibrinolytic activity using the Euglobulin Clot Lysis Time (ECLT) method.
Results:
Our data show that Mox-LDL decreases endothelial cell fibrinolytic capacity by upregulating neuroserpin in lox-1 knockdown cells.
Conclusions:
Lox-1 protects the endothelial cells from a Mox-LDL-induced decrease in pro-fibrinolytic capacity, which has important consequences in the context of stroke.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

